Showing 9,754 results

Filters Content type: News, Editors' picks Topic: Health services & systems

Getting the most from doctors, nurses, pharmacists and other healthcare providers.

Access to healthcare

Dutch survey finds informal use of doxyPEP is rising

Editor's pick
CIDRAP
10 July 2025
Pharmaceutical industry

HIV drugmaker Theratechnologies agrees to $254M buyout by CDMO Future Pak

Editor's pick
FiercePharma
10 July 2025
Conference announcements & declarations

IAS 2025 Preview: Amidst a Worldwide Funding Emergency, HIV Science Moves Forward

Editor's pick
TheBodyPro
10 July 2025
Injectable & long-acting PrEP

Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries

Editor's pick
Global Fund News Releases
10 July 2025
Injectable & long-acting PrEP

Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost

Editor's pick
STAT (requires free registration)
10 July 2025
Government, leadership & policy

South Africans fear spike in HIV infections as US aid cuts bite

Editor's pick
BBC News
10 July 2025
Epidemiology

Millions at Risk of HIV Infection and Death After US Funding Cuts, Warns UNAIDS

Editor's pick
Health Policy Watch
10 July 2025
Finance & funding

South Africa: Treasury hands HIV response a lifeline, but it’s probably too little

Editor's pick
GroundUp News
10 July 2025
Global health initiatives

Global Fund plans to cut $1.4 billion from grants it has already awarded

Editor's pick
Devex (requires free registration)
10 July 2025
Global health initiatives

Board agrees for UNAIDS to use its reserves for restructuring

Editor's pick
Devex (requires free registration)
10 July 2025
Conference announcements & declarations

Coming soon: news from IAS 2025

News
7 July 2025
Global health initiatives

UNAids chief ‘shaken and disgusted’ by US cuts that will mean millions more deaths

Editor's pick
The Guardian
7 July 2025
Pharmaceutical industry

CytoDyn must face investor lawsuit alleging misleading claims in COVID, HIV drug debacle

Editor's pick
FierceBiotech
7 July 2025
Clinical trials

Nearly 75% of pivotal cancer trials in past 5 years exclude people living with HIV

Editor's pick
Healio
7 July 2025
Pharmaceutical industry

Gilead’s Voluntary License on Lenacapavir: Key Limitations of the License and Recommendations to Improve Access

Editor's pick
Médecins Sans Frontières
7 July 2025
Finance & funding

NIH restores grants to South Africa scientists, adds funding option for other halted foreign projects

Editor's pick
Science Magazine
4 July 2025
People & personal stories

Professor screw it, let’s do it: Francois Venter

Editor's pick
Bhekisisa
30 June 2025
Improving HIV care

ECDC releases new standards to improve HIV prevention and care

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
27 June 2025
PrEP policies & guidelines

Supreme Court endorses Obamacare panel that requires free preventive care

Editor's pick
NBC News
27 June 2025
Treatment guidelines

Federal HIV Guidelines Face a Shutdown — A Critical Loss for Clinicians and Patients

Editor's pick
HIV and ID Observations
24 June 2025
Health services & systems

Village Apothecary Continues to Go Above and Beyond

Editor's pick
POZ
24 June 2025
Global health initiatives

Will UNAIDS sunset by 2030?

Editor's pick
Devex (requires free registration)
19 June 2025
Injectable & long-acting PrEP

HIV protection with just two shots a year: FDA approves Gilead drug

Editor's pick
STAT
19 June 2025
Injectable & long-acting PrEP

Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection

Editor's pick
Gilead Sciences press release
19 June 2025